A pilot study investigating the role of
Anal canal
cancer
positron emission tomography
radiotherapy
response
Journal
Journal of medical radiation sciences
ISSN: 2051-3909
Titre abrégé: J Med Radiat Sci
Pays: United States
ID NLM: 101620352
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
17
03
2022
accepted:
19
07
2022
pubmed:
31
7
2022
medline:
6
12
2022
entrez:
30
7
2022
Statut:
ppublish
Résumé
Anal cancer (AC) is Eleven patients with AC referred for chemoradiotherapy were prospectively enrolled into this study, with 10 meeting eligibility requirements. Nine patients were qualitatively classified as complete metabolic responders at TP2 and all 10 at TP3. All quantitative measures demonstrated significant (P < 0.05) reductions at TP2 for both Manual and Threshold methods. All reduced further at TP3 and again at TP4 for Threshold methods. TLG showed the highest reduction at all post-chemoradiotherapy time points and classified the most responders for each method at each time point. All patients are recurrence-free at minimum 4-year follow-up. Based on our small sample size, semi-automated methods of disease definition using
Identifiants
pubmed: 35906833
doi: 10.1002/jmrs.611
pmc: PMC9714497
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Radiopharmaceuticals
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
439-447Subventions
Organisme : Royal Australian and New Zealand College of Radiologists
ID : 2015\RANZCR\007
Informations de copyright
© 2022 The Authors. Journal of Medical Radiation Sciences published by John Wiley & Sons Australia, Ltd on behalf of Australian Society of Medical Imaging and Radiation Therapy and New Zealand Institute of Medical Radiation Technology.
Références
Nucl Med Commun. 2016 Oct;37(10):1038-45
pubmed: 27341410
Lancet Oncol. 2017 Mar;18(3):347-356
pubmed: 28209296
Ann Nucl Med. 2001 Dec;15(6):471-86
pubmed: 11831394
Am J Nucl Med Mol Imaging. 2011;1(1):54-62
pubmed: 23133795
Acta Oncol. 2013 Apr;52(3):619-26
pubmed: 22873767
J Med Imaging Radiat Oncol. 2014 Feb;58(1):18-24
pubmed: 24529051
Br J Cancer. 2011 Aug 9;105(4):498-504
pubmed: 21792197
J Clin Oncol. 2003 Apr 1;21(7):1285-92
pubmed: 12663716
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):771-8
pubmed: 17398018
Radiother Oncol. 2008 Jun;87(3):376-82
pubmed: 18453023
Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1583-93
pubmed: 17503039
Eur J Cancer. 1999 Dec;35(13):1773-82
pubmed: 10673991
J Nucl Med. 2007 Sep;48(9):1449-58
pubmed: 17704250
Radiology. 2005 Dec;237(3):1038-45
pubmed: 16304117
J Clin Oncol. 2003 Jul 1;21(13):2574-82
pubmed: 12829678
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):66-72
pubmed: 22592047
Clin Oncol (R Coll Radiol). 2005 Aug;17(5):364-6
pubmed: 16097568
Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1427-38
pubmed: 17431616
Int J Colorectal Dis. 2011 Feb;26(2):201-10
pubmed: 21061012
Dis Colon Rectum. 1984 Dec;27(12):763-6
pubmed: 6499614
Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1574-97
pubmed: 14579100
Eur J Surg Oncol. 2014 Oct;40(10):1165-76
pubmed: 25239441
J Natl Compr Canc Netw. 2018 Jul;16(7):852-871
pubmed: 30006428
Eur J Nucl Med Mol Imaging. 2006 Jul;33(7):770-8
pubmed: 16550384
J Nucl Med. 2006 Aug;47(8):1241-8
pubmed: 16883000